Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

American Renal Associates Holdings, Inc. (ARA) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/05/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
01/27/2021 SC 13G/A Centerbridge Credit Partners, L.P. reports a 0% stake in American Renal Associates Holdings, Inc.
01/27/2021 4 CENTERBRIDGE CAPITAL PARTNERS L P (10% Owner) has filed a Form 4 on American Renal Associates Holdings, Inc.
Txns: Disposed of 16,893,850 shares @ $0
Disposed of 523,697 shares @ $0
Disposed of 198,289 shares @ $0
01/26/2021 4 ERICKSON THOMAS W (Director) has filed a Form 4 on American Renal Associates Holdings, Inc.
Txns: Disposed/sold 49,435 shares @ $0
Disposed/sold 18,320 shares @ $0
01/26/2021 4 Hocevar Christopher J (Director) has filed a Form 4 on American Renal Associates Holdings, Inc.
Txns: Disposed/sold 18,679 shares @ $0
01/26/2021 4 Carlucci Joseph A (CEO) has filed a Form 4 on American Renal Associates Holdings, Inc.
Txns: Disposed/sold 590,879 shares @ $0
Disposed/sold 654,285 shares @ $0
Disposed/sold 199,307 options to buy @ $6.47, valued at $1.3M
01/26/2021 4 Jureller John M (Director) has filed a Form 4 on American Renal Associates Holdings, Inc.
Txns: Disposed/sold 49,435 shares @ $0
01/26/2021 4 Kamal Syed T (President) has filed a Form 4 on American Renal Associates Holdings, Inc.
Txns: Disposed/sold 1,291,236 shares @ $0
Disposed/sold 199,307 options to buy @ $6.47, valued at $1.3M
01/26/2021 4 Labriola Victoria (VP and General Counsel) has filed a Form 4 on American Renal Associates Holdings, Inc.
Txns: Disposed/sold 64,569 shares @ $0
Disposed/sold 15,949 options to buy @ $6.27, valued at $100k
Disposed/sold 9,139 options to buy @ $10.19, valued at $93.1k
01/26/2021 4 FISH ROBERT H (Director) has filed a Form 4 on American Renal Associates Holdings, Inc.
Txns: Disposed/sold 43,205 shares @ $0
01/26/2021 4 Williamson Don E (EVP, COO) has filed a Form 4 on American Renal Associates Holdings, Inc.
Txns: Disposed/sold 307,282 shares @ $0
Disposed/sold 11,970 options to buy @ $1.28, valued at $15.3k
Disposed/sold 5,725 options to buy @ $6.47, valued at $37k
01/26/2021 4 BOXER MICHAEL (Director) has filed a Form 4 on American Renal Associates Holdings, Inc.
Txns: Disposed/sold 13,801 shares @ $0
Disposed/sold 53,954 shares @ $0
Disposed/sold 32,713 shares @ $0
01/26/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
01/26/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/26/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
01/26/2021 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Fourth Amended and Restated Certificate of Incorporation of American Renal Associates Holdings, Inc",
"Second Amended and Restated Bylaws of American Renal Associates Holdings, Inc",
"BEVERLY, Mass. — Nautic Partners and its portfolio company, Innovative Renal Care , have completed the previously announced transaction to acquire American Renal Associates Holdings, Inc. , effective January 25, 2021. The transaction creates a unique opportunity to shape the future of kidney care during a dynamic time of change, innovation and transformation in the industry. “As the healthcare industry continues to evolve, recent innovation throughout kidney and renal care has allowed for dramatic and exciting improvements in care delivery and patient experience,” said Nick Mendez, president and CEO of IRC. “ARA’s significant infrastructure and geographic footprint provides a unique opportunity to advance the development of a comprehensive renal care model for the patients and communities ..."
01/14/2021 8-K Quarterly results
01/06/2021 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/30/2020 GN SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – WTRE, ARA, RESI, NK
12/24/2020 GN ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers – STND, EIDX, ARA, RESI
12/15/2020 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
12/01/2020 GN Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – ARA, PNM, IPHI, EIGI
12/01/2020 GN SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IPHI, ARA, PNM, and EIGI Buyouts
11/25/2020 GN Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm ?? ARA, CIT, CXO, RESI
11/25/2020 GN SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of ARA, CEIX, MVC, and MCEP Mergers
11/24/2020 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
11/07/2020 GN SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – EIDX, WTRE, ARA, CIT
11/05/2020 10-Q Quarterly Report for the period ended September 30, 2020
10/30/2020 GN Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), and CIT Group Inc. (NYSE:CIT) and Mid-Con Energy Partners, LP (NASDAQ: MCEP)
10/19/2020 GN SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, ARA, MVC, and CGIX Mergers
10/15/2020 GN Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Cellular Biomedicine Group, Inc., and Eidos Therapeutics, Inc.
10/09/2020 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/05/2020 GN SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of American Renal Associates Holdings, Inc. Buyout
10/02/2020 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy